259 related articles for article (PubMed ID: 27547294)
21. Effect of miR-499a-5p on damage of cardiomyocyte induced by hypoxia-reoxygenation via downregulating CD38 protein.
Zhao L; Wang B; Zhang W; Sun L
J Cell Biochem; 2020 Feb; 121(2):996-1004. PubMed ID: 31452254
[TBL] [Abstract][Full Text] [Related]
22. Cardiac Sirt1 mediates the cardioprotective effect of caloric restriction by suppressing local complement system activation after ischemia-reperfusion.
Yamamoto T; Tamaki K; Shirakawa K; Ito K; Yan X; Katsumata Y; Anzai A; Matsuhashi T; Endo J; Inaba T; Tsubota K; Sano M; Fukuda K; Shinmura K
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H1003-14. PubMed ID: 26873964
[TBL] [Abstract][Full Text] [Related]
23. Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3β RISK pathway.
Sulaiman D; Li J; Devarajan A; Cunningham CM; Li M; Fishbein GA; Fogelman AM; Eghbali M; Reddy ST
J Mol Cell Cardiol; 2019 Apr; 129():154-164. PubMed ID: 30802459
[TBL] [Abstract][Full Text] [Related]
24. NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis.
Cattelan A; Ceolotto G; Bova S; Albiero M; Kuppusamy M; De Martin S; Semplicini A; Fadini GP; de Kreutzenberg SV; Avogaro A
Vascul Pharmacol; 2015 Jul; 70():35-44. PubMed ID: 25863291
[TBL] [Abstract][Full Text] [Related]
25. Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor 1 of Protein Phosphatase 1 Protects Against Myocardial Ischemia-Reperfusion Injury.
Yu J; Chen Y; Xu M; Sun L; Luo H; Bao X; Meng G; Zhang W
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):460-473. PubMed ID: 31030549
[TBL] [Abstract][Full Text] [Related]
26. Rno-microRNA-30c-5p promotes myocardial ischemia reperfusion injury in rats through activating NF-κB pathway and targeting SIRT1.
Chen J; Zhang M; Zhang S; Wu J; Xue S
BMC Cardiovasc Disord; 2020 May; 20(1):240. PubMed ID: 32434515
[TBL] [Abstract][Full Text] [Related]
27. rAAV9-Mediated MEK1 Gene Expression Restores Post-conditioning Protection Against Ischemia Injury in Hypertrophic Myocardium.
Chen Y; Liu F; Chen BD; Li XM; Huang Y; Yu ZX; Gao XL; He CH; Yang YN; Ma YT; Gao XM
Cardiovasc Drugs Ther; 2020 Feb; 34(1):3-14. PubMed ID: 32103377
[TBL] [Abstract][Full Text] [Related]
28. Exendin-4 Protects Against Myocardial Ischemia-Reperfusion Injury by Upregulation of SIRT1 and SIRT3 and Activation of AMPK.
Eid RA; Bin-Meferij MM; El-Kott AF; Eleawa SM; Zaki MSA; Al-Shraim M; El-Sayed F; Eldeen MA; Alkhateeb MA; Alharbi SA; Aldera H; Khalil MA
J Cardiovasc Transl Res; 2021 Aug; 14(4):619-635. PubMed ID: 32239434
[TBL] [Abstract][Full Text] [Related]
29.
Sun T; Zhang Y; Zhong S; Gao F; Chen Y; Wang B; Cai W; Zhang Z; Li W; Lu S; Zheng F; Shi G
Front Pharmacol; 2018; 9():19. PubMed ID: 29422863
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of miR-34a-5p protected myocardial ischemia reperfusion injury-induced apoptosis and reactive oxygen species accumulation through regulation of Notch Receptor 1 signaling.
Wang Z; Wang Z; Wang T; Yuan J; Wang X; Zhang Z
Rev Cardiovasc Med; 2019 Sep; 20(3):187-197. PubMed ID: 31601093
[TBL] [Abstract][Full Text] [Related]
31. Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury.
Braunersreuther V; Montecucco F; Asrih M; Pelli G; Galan K; Frias M; Burger F; Quinderé AL; Montessuit C; Krause KH; Mach F; Jaquet V
J Mol Cell Cardiol; 2013 Nov; 64():99-107. PubMed ID: 24051369
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial LonP1 protects cardiomyocytes from ischemia/reperfusion injury in vivo.
Venkatesh S; Li M; Saito T; Tong M; Rashed E; Mareedu S; Zhai P; Bárcena C; López-Otín C; Yehia G; Sadoshima J; Suzuki CK
J Mol Cell Cardiol; 2019 Mar; 128():38-50. PubMed ID: 30625302
[TBL] [Abstract][Full Text] [Related]
33. Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis.
Zhang X; Li Y; Wang Y; Zhuang Y; Ren X; Yang K; Ma W; Zhong M
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406910
[TBL] [Abstract][Full Text] [Related]
34. 20-Hydroxyeicosatetraenoic acid mediates isolated heart ischemia/reperfusion injury by increasing NADPH oxidase-derived reactive oxygen species production.
Han Y; Zhao H; Tang H; Li X; Tan J; Zeng Q; Sun C
Circ J; 2013; 77(7):1807-16. PubMed ID: 23585488
[TBL] [Abstract][Full Text] [Related]
35. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J
Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608
[TBL] [Abstract][Full Text] [Related]
36. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.
Yang FY; Zhang L; Zheng Y; Dong H
Bioengineered; 2022 Jan; 13(1):1377-1387. PubMed ID: 34974801
[TBL] [Abstract][Full Text] [Related]
37. Targeted focal adhesion kinase activation in cardiomyocytes protects the heart from ischemia/reperfusion injury.
Cheng Z; DiMichele LA; Hakim ZS; Rojas M; Mack CP; Taylor JM
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):924-33. PubMed ID: 22383703
[TBL] [Abstract][Full Text] [Related]
38. Isorhamnetin protects against hypoxia/reoxygenation-induced injure by attenuating apoptosis and oxidative stress in H9c2 cardiomyocytes.
Zhao TT; Yang TL; Gong L; Wu P
Gene; 2018 Aug; 666():92-99. PubMed ID: 29730426
[TBL] [Abstract][Full Text] [Related]
39. Oxidative activation of type III CD38 by NADPH oxidase-derived hydrogen peroxide in Ca
Park DR; Nam TS; Kim YW; Bae YS; Kim UH
FASEB J; 2019 Mar; 33(3):3404-3419. PubMed ID: 30452880
[TBL] [Abstract][Full Text] [Related]
40. Kaempferol protects cardiomyocytes against anoxia/reoxygenation injury via mitochondrial pathway mediated by SIRT1.
Guo Z; Liao Z; Huang L; Liu D; Yin D; He M
Eur J Pharmacol; 2015 Aug; 761():245-53. PubMed ID: 26086862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
